How Blood Tests Could Hold the Key to Helping Smokers Quit
The rate at which individual smokers break down nicotine in their blood determines their best strategy, researchers say.
Researchers from the University of Pennsylvania enlisted some 1,240 people on different smoking cessation programs. Volunteers were given either nicotine patches, a non-nicotine based prescription drug called varenicline, or a placebo. Their blood was tested to see whether nicotine broke down at a normal or slower rate, while doctors balanced potential side-effects against the harms of continued smoking.
The study, published in a Lancet medical journal, concluded that those volunteers who broke down nicotine at a normal rate had a better chance of quitting with varenicline than they did with nicotine replacement patches. The volunteers who broke down nicotine at a slower rate benefited equally from all three methods, on the other hand—but they experienced more side effects with varenicline.
Professor Caryn Lerman, who led the research team, says that for some smokers who have a normal metabolism of nicotine, “The chance of success might be low on the patches but could double if they take the pill.” Meanwhile, “for a third of the population with slower breakdown, cheaper patches might be best.” However, Professor Neil Davis of the University of Bristol says that “The cost-effectiveness of these tests would need to be taken into account.” Scientists have so far only used these blood tests for research but say they could easily be developed for wider use.
You Might Also Like
Many soldiers have returned from the wars in Afghanistan and Iraq with PTSD, concussions and traumatic brain injuries, mangled limbs and chronic pain—the result of roadside bombs and other guerilla... Read More
A crisis that kills 91 Americans every day and controls the lives of nearly 2.6 million, the opioid epidemic is very much out of control. There remains a huge gap between what is known about... Read More
Recent media reports have given significant attention to the spread of opioid addiction in suburban America. We can no longer view drug addiction as an inner-city issue that affects a small portion... Read More
Sam’s struggle with schizophrenia has led to substance abuse. His doctors say medication could help get both diagnoses under control, but he finds it difficult to maintain a regular dosage... Read More
Nearly 5,000 people. That was the meth death toll in 2015. This number has risen dramatically since 2010. In fact, between 2010 and 2014, it doubled. 897,000 people. That’s the estimated number... Read More